USD 61.81
(-11.41%)
Breakdown | 2023 | 2022 | 2021 |
---|---|---|---|
Operating Cash Flow | -11.73 Million | -37.24 Million | 389.96 Thousand |
Net Income | -4.14 Million | -3.92 Million | -4.03 Million |
Depreciation & Amortization | - | - | 767.62 Thousand |
Deferred income taxes | - | - | - |
Stock-based compensation | - | - | - |
Change in working capital | -490.6 Thousand | -7.84 Million | 2.13 Million |
Other non-cash items | 72.17 Thousand | -25.37 Million | 1.64 Million |
Investing Cash Flow | -8.46 Million | -26.46 Million | -45.38 Million |
Investments in PPE | 1.00 | - | - |
Acquisitions | - | - | - |
Investment purchases | -5.11 Million | -13.31 Million | -6.99 Million |
Sales/Maturities of investments | 13.57 Million | 39.77 Million | 52.38 Million |
Other Investing Activities | -16.92 Million | - | - |
Financing Cash Flow | -291.51 Thousand | 2.5 Million | 91.76 Million |
Debt repayment | - | -2.39 Million | -87.67 Million |
Dividends payments | -75 Thousand | - | - |
Common Stock Repurchased | - | - | - |
Common Stock Issuance | - | 106.52 Thousand | 4.09 Million |
Other Financing Activities | -216.51 Thousand | 2.5 Million | - |
Accounts receivables | -8132.00 | -184.25 Thousand | - |
Accounts payables | -392.87 Thousand | -7.76 Million | 1.4 Million |
Inventory | - | - | - |
Other working capital | -89.59 Thousand | 107.65 Thousand | 732.3 Thousand |
Cash at beginning of period | 12.02 Million | 46.76 Million | - |
Cash at end of period | -8.46 Million | 12.02 Million | 46.76 Million |
Capital Expenditure | 1.00 | - | - |
Effect of forex changes on cash | - | - | - |
Net cash flow / Change in cash | -20.48 Million | -34.74 Million | 46.76 Million |
Free Cash Flow | -11.73 Million | -37.24 Million | 389.96 Thousand |
Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 | 2021 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -4.14 Million | -1.47 Million | -2.66 Million | -3.92 Million | -9.8 Million | -4.03 Million |
Depreciation & Amortization | - | - | - | - | - | 767.62 Thousand |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -490.6 Thousand | -1.03 Million | 541.74 Thousand | -7.84 Million | 23.6 Million | 2.13 Million |
Other non-cash items | 72.17 Thousand | 1.14 Million | 613.68 Thousand | -25.37 Million | -15.76 Million | 1.64 Million |
Investing Cash Flow | -8.46 Million | 2.61 Million | -11.08 Million | -26.46 Million | 2.91 Million | -45.38 Million |
Investments in PPE | - | 1.00 | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -5.11 Million | -4.88 Million | -229.61 Thousand | -13.31 Million | -3.03 Million | -6.99 Million |
Sales/Maturities of investments | 13.57 Million | 2.26 Million | 11.31 Million | 39.77 Million | 119.91 Thousand | 52.38 Million |
Other Investing Activities | - | 5.23 Million | - | - | - | - |
Financing Cash Flow | -291.51 Thousand | -291.51 Thousand | - | 2.5 Million | - | 91.76 Million |
Debt repayment | - | - | - | -2.39 Million | - | -87.67 Million |
Dividends payments | -75 Thousand | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | 106.52 Thousand | - | 4.09 Million |
Other Financing Activities | -216.51 Thousand | -291.51 Thousand | - | 2.5 Million | - | - |
Accounts receivables | -8132.00 | -52.1 Thousand | 43.97 Thousand | -184.25 Thousand | -97.11 Thousand | - |
Accounts payables | -392.87 Thousand | -916.65 Thousand | 523.78 Thousand | -7.76 Million | -1.35 Million | 1.4 Million |
Inventory | - | - | - | - | - | - |
Other working capital | -89.59 Thousand | -63.58 Thousand | -26.01 Thousand | 107.65 Thousand | 25.44 Million | 732.3 Thousand |
Cash at beginning of period | 12.02 Million | - | 12.02 Million | 46.76 Million | 12.53 Million | - |
Cash at end of period | -8.46 Million | - | - | 12.02 Million | 12.02 Million | 46.76 Million |
Capital Expenditure | - | 1.00 | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -20.48 Million | - | -12.02 Million | -34.74 Million | -509.23 Thousand | 46.76 Million |
Free Cash Flow | -11.73 Million | -2.32 Million | -942.71 Thousand | -37.24 Million | -3.41 Million | 389.96 Thousand |
0396
TRU
HALB
BAFN
PHARMAID
FUAPF